Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7654318rdf:typepubmed:Citationlld:pubmed
pubmed-article:7654318lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:7654318lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:7654318lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:7654318lifeskim:mentionsumls-concept:C1158884lld:lifeskim
pubmed-article:7654318pubmed:issue11-12lld:pubmed
pubmed-article:7654318pubmed:dateCreated1995-10-5lld:pubmed
pubmed-article:7654318pubmed:abstractTextThe antiapoptosis potential of bcl-2 has now been well established. But the biochemical mechanism of bcl-2 action is still poorly understood. Using the phosphatase inhibitor okadaic acid (OA) or chemotherapeutic agents such as Taxol and 5'-fluorouracil, we found that bcl-2 can be phosphorylated. Since OA or Taxol treatment leads to apoptosis, it seems that phosphorylation of bcl-2 leads to its inactivation. Exposure of several lymphoid cell lines expressing differential amounts of bcl-2 protein to OA resulted in apoptosis of the cells and hyperphosphorylation of bcl-2. Interestingly, the lymphoblastoid cell lines that did not phosphorylate bcl-2 following OA exposure did not undergo apoptosis. Moreover, pro-B cells isolated from patients with acute lymphoblastic leukemias exhibited endogenous phosphorylated forms of bcl-2 and a large number of apoptotic cells, even without OA treatment. Treatment with the phosphatase inhibitor or with chemotherapeutic agents (Taxol, 5'-fluorouracil) led to severe apoptosis of these cells, along with hyperphosphorylation of bcl-2. Phosphoamino acid analysis reveals that bcl-2 is phosphorylated at a serine residue. In summary, our investigation indicates that the phosphorylation pathway involving bcl-2 can be the determinant of cell death in lymphocytes.lld:pubmed
pubmed-article:7654318pubmed:languageenglld:pubmed
pubmed-article:7654318pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:citationSubsetIMlld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7654318pubmed:statusMEDLINElld:pubmed
pubmed-article:7654318pubmed:issn0829-8211lld:pubmed
pubmed-article:7654318pubmed:authorpubmed-author:CroceC MCMlld:pubmed
pubmed-article:7654318pubmed:authorpubmed-author:HaldarSSlld:pubmed
pubmed-article:7654318pubmed:authorpubmed-author:JenaNNlld:pubmed
pubmed-article:7654318pubmed:issnTypePrintlld:pubmed
pubmed-article:7654318pubmed:volume72lld:pubmed
pubmed-article:7654318pubmed:geneSymbolbcl-2lld:pubmed
pubmed-article:7654318pubmed:ownerNLMlld:pubmed
pubmed-article:7654318pubmed:authorsCompleteYlld:pubmed
pubmed-article:7654318pubmed:pagination455-62lld:pubmed
pubmed-article:7654318pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:meshHeadingpubmed-meshheading:7654318-...lld:pubmed
pubmed-article:7654318pubmed:articleTitleAntiapoptosis potential of bcl-2 oncogene by dephosphorylation.lld:pubmed
pubmed-article:7654318pubmed:affiliationJefferson Cancer Institute, Jefferson Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.lld:pubmed
pubmed-article:7654318pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7654318pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7654318pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7654318lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7654318lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7654318lld:pubmed